Literature DB >> 33304739

Kinetic Target-Guided Synthesis of Small-Molecule G-Quadruplex Stabilizers.

Alice Pomeislová1,2, Lukáš Vrzal1,3, Jaroslav Kozák1, Juraj Dobiaš1, Martin Hubálek1, Hana Dvořáková3, Paul E Reyes-Gutiérrez1, Filip Teplý1, Václav Veverka1,4.   

Abstract

The formation of a G-quadruplex motif in the promoter region of the c-MYC protooncogene prevents its expression. Accordingly, G-quadruplex stabilization by a suitable ligand may be a viable approach for anticancer therapy. In our study, we used the 4-(4-methylpiperazin-1-yl)aniline molecule, previously identified as a fragment library screen hit, as a template for the SAR-guided design of a new small library of clickable fragments and subjected them to click reactions, including kinetic target-guided synthesis in the presence of a G-quadruplex forming oligonucleotide Pu24. We tested the clickable fragments and products of click reactions for their G-quadruplex stabilizing activity and determined their mode of binding to the c-MYC G-quadruplex by NMR spectroscopy. The enhanced stabilizing potency of click products in biology assays (FRET, Polymerase extension assay) matched the increased yields of in situ click reactions. In conclusion, we identified the newly synthesized click products of bis-amino derivatives of 4-(4-methylpiperazin-1-yl)aniline as potent stabilizers of c-MYC G-quadruplex, and their further evolution may lead to the development of an efficient tool for cancer treatment.
© 2020 The Authors. Published by Wiley-VCH GmbH.

Entities:  

Keywords:  G-quadruplex; NMR; anticancer therapy; click chemistry; secondary structures

Year:  2020        PMID: 33304739      PMCID: PMC7713561          DOI: 10.1002/open.202000261

Source DB:  PubMed          Journal:  ChemistryOpen        ISSN: 2191-1363            Impact factor:   2.911


Introduction

Poly‐guanine tracts in nucleic acids form non‐canonical structures known as G‐quadruplexes (G4s), which were recognized as an attractive class of targets for therapeutic intervention in cancer,[ , , ] particularly for their role in regulating the expression of key oncogenes. It was found that stabilization of G4 near the c‐MYC gene promoter using a small molecule can reduce the levels of the c‐MYC oncoprotein in the nucleus. Increased c‐MYC oncoprotein expression is typical of many cancers and often associated with poor prognosis (aggressive tumors, poor clinical outcome and increased metastasis, recurrence and mortality rates).[ , , , ] Therefore, G4 stabilization to reduce c‐MYC expression is one of the potential anticancer strategies.[ , ] The G4 motif, a key regulatory element of the human c‐MYC gene, is located downstream of the promoter region of the c‐MYC gene in the nuclease hypersensitive element III1 (NHE III1) that controls over 80 % of the c‐MYC transcriptional activity.[ , ] The NHE III1 comprises the core 27‐nucleotide sequence of the wild‐type c‐MYC (Pu27) that contains six guanine tracts and can thus form multiple G4s.[ , , , , ] Apart from that, other biologically relevant sequences have been described, e. g., the ′propeller type′ parallel‐stranded G4 sequence containing the four central guanine tracts of Pu27, or the 24‐nucleotide five‐guanine‐tract sequence (Pu24) forming a parallel‐stranded foldback G4. Generally, the c‐MYC ligands are planar aromatic molecules that interact with the G4 scaffold via external π‐π stacking. In addition, electrostatic interactions between positively charged ligands and negatively charged G4‐DNA scaffolds contribute to G4 stabilization. The known c‐MYC binders include e. g., the cationic porphyrin TMPyP4, the synthetic fluorescent dye Hoechst 33258,[ , ] quindoline[ , ] and berberine derivatives, carbazoles, perylene derivatives, the fluoroquinolone derivative quarfloxin,[ , ] and the 1,4‐dihydroxyanthracene‐9,10‐dione derivative MYRA‐A. More recently, various 4‐anilinoquinazoline derivatives as well as the crescent‐shaped thiazole peptide TH3 were found to down‐regulate transcription and expression of the c‐MYC gene in HeLa cells. Other newly reported c‐MYC ligands comprised functionalized imidazo[2,1‐i]purine derivatives and fluorescent binaphthyl amines. The rational design of novel potent and selective G4 ligands is inherently difficult due to the dynamic nature of typical G4 structures. Recently, kinetic target‐guided synthesis (KTGS) proved successful in the development of novel inhibitors of several enzymes with improved selectivity.[ , , , , , ] In KTGS, the target molecule is exploited to irreversibly assemble its own inhibitor (ligand) in situ by joining two suitable fragments with complementary reactive groups via a ′click reaction′. This term typically refers to a 1,3‐dipolar cycloaddition between azides and terminal alkynes that leads to triazole formation, although there are several alternative reactions (as reviewed in ref. ). Specific interactions between fragments and the biological target bring the two molecules into close proximity with a suitable orientation, which decreases the negative ▵S≠ values of 1,3‐dipolar cycloaddition, thereby overcoming the otherwise low reaction rate under non‐catalyzed conditions. During in situ click experiments, the target molecule controls the assembly of the best alkyne and azide within a pool of available fragments present in the reaction mixture. By directing the choice of the best binding partner, the active site of a biological target promotes the synthesis of the most efficient ligand/inhibitor.[ , , , , , , , , ] KTGS employing in situ click chemistry allows to build novel and unique ligands by combining suitable fragments and to improve previously established ligands towards fine‐tuning their selectivity and bioavailability. To date, KTGS has been only used to stabilize telomeric G4.[ , ] Here, we present the in situ development of c‐MYC G4 stabilizers by KTGS using a 4‐(4‐methylpiperazin‐1‐yl)aniline molecule that was active in the previous library screen targeting c‐MYC G4. We successfully modified this scaffold for click chemistry and prepared a series of compounds through both in situ and conventional chemical synthesis. The clickable fragments and the synthesized click products were tested for their G4 stabilizing activity, and their mode of binding to c‐MYC G4 was characterized using NMR spectroscopy. The combination of biochemical assays, in situ click experiments, and NMR data provided a basis for the characterization of structure‐activity relationships that led to the successful development of c‐MYC G4 stabilizers.

Results and Discussion

Choice of Fragment Template

Initially, we tested the 11 fragments (Figure 1), which were reported by Nasiri et al as c‐MYC ligands, in in vitro assays to evaluate their c‐MYC G4‐stabilizing potential. In particular, we employed a standard polymerase extension assay (PEA) using a template strand containing the Pu27 sequence and tested thermal stabilization of G4‐forming Pu25 oligonucleotide detected by Förster resonance energy transfer (FRET). All compounds from this set produced a stop band in PEA at 500 μM, and compound 7 was the strongest G4 stabilizer (ESI, Section 3.1, Figure S3.1 and S3.2). In addition, compound 7 induced a significant thermal stabilization effect on the labeled Pu25 oligonucleotide in FRET, with a melting temperature increase of 10.4±0.6 °C at 100 μM, indicating that this compound has a significantly higher binding affinity to c‐MYC G4 than other compounds in the respective set (data not shown).
Figure 1

The 11 published compounds (1‐11) which were found as c‐MYC ligands in a previously performed fragment library screen. The FRET and PEA assays suggested fragment 7 as the best ligand and it was therefore selected for further elaboration.

The 11 published compounds (1‐11) which were found as c‐MYC ligands in a previously performed fragment library screen. The FRET and PEA assays suggested fragment 7 as the best ligand and it was therefore selected for further elaboration. Additionally, a significant fraction of compound 7 is incorporated into the fluorescent dye Hoechst 333258 that was previously reported as a c‐MYC ligand.[ , ] Therefore, we decided to use the structure of 7 as a template to build a focused fragment library through synthetic elaboration.

Focused Fragment Library

In order to design new molecules with enhanced c‐MYC affinity, we aimed to construct a small focused fragment library derived from compound 7 that would be amenable for KTGS. Before functionalizing compound 7 for click chemistry, it was necessary to ascertain the role of various chemical moieties of this parent compound 7 in c‐MYC stabilization. For this purpose, a set of commercially available derivatives of compound 7 that contained modifications at the piperazine and/or at the aniline moiety was provided (Figure 2, 12–23). All the compounds 12–23 were tested in FRET melting assay and in PEA at 100 μM for their c‐MYC binding ability and compared to the parent compound 7 (for PEA gel images, see ESI, Section 3.2, Figure S3.3 and S3.4). The only molecule that exhibited significantly increased FRET activity and retention of PEA activity compared to compound 7 was the bis‐amino derivative 17 containing an additional amino moiety in position 2 of the aromatic ring. With ΔT m increase exceeding 35 °C, compound 17 exhibited more than 3‐fold ΔT m increase in FRET relative to the parent molecule 7. Furthermore, the reduced activity of the nitro analogue 12 and inactivity of the compounds 13 and 14 isomeric to 7 suggested necessity of the amino group at the para‐position of the aromatic ring for interaction of the ligand with c‐MYC. Therefore, this amino moiety cannot be used for further derivatization. Finally, inactivity of compound 15 with an unsubstituted N 4‐piperazine position and partial restoration of PEA activity for compound 16 underlines the need of an aliphatic substituent at this piperazine nitrogen.
Figure 2

A set of 4‐(4‐methylpiperazin‐1‐yl)aniline derivatives containing various chemical moieties. Compounds 12–23 were obtained from commercial sources.

A set of 4‐(4‐methylpiperazin‐1‐yl)aniline derivatives containing various chemical moieties. Compounds 12–23 were obtained from commercial sources. Based on these findings, we constructed a fragment library (Figure 3A and 3B) that consisted of two different families of N‐alkyne compounds: a monoamino series directly derived from 7 (Figure 3A) and a bis‐amino series containing an additional amino functional group at position 2 of the aromatic ring (Figure 3B). Both series included ′clickable′ compounds alkynylated at the N 4‐piperazine position and the resulting click products. The design of both series was guided by a SAR study performed simultaneously with compound synthesis.
Figure 3

4‐(piperazin‐1‐yl)aniline‐derived fragment library constructed in the present study. (A) Mono‐amino series. (B) Bis‐amino series. (C) Azides used for CuAAC. Compounds from both series (A and B) are sorted by type of reaction whereby they were prepared.

4‐(piperazin‐1‐yl)aniline‐derived fragment library constructed in the present study. (A) Mono‐amino series. (B) Bis‐amino series. (C) Azides used for CuAAC. Compounds from both series (A and B) are sorted by type of reaction whereby they were prepared. The mono‐amino series was synthesized by N‐alkylation of the piperazine moiety of 4‐(piperazin‐1‐yl)aniline (compound 15) with three different alkynyl halides of various chain lengths to investigate influence of molecule flexibility on interaction with c‐MYC. Thus, we prepared a homologous series of three alkynes with 1, 2 or 3 methylene units in the alkynyl chain, that is, 24, 25, and 26 (Figure 3A), respectively. Compounds 24–26 were directly coupled to four selected azides 52–55 (Figure 3C) in a CuI‐catalyzed 1,3‐dipolar cycloaddition (CuAAC), referred to as ′click reaction′, upon 1,4‐triazole formation (products 27–38, Figure 3A). The choice of azides 52–53 and 55 was directly inspired by the study performed by Di Antonio et al and azide 54 was included as a tertiary‐amine analogue to compound 53. The click product 40, a nitro analog of 38, was obtained from the nitroalkyne 39 and served as a negative control to assess whether the amino group is essential for electrostatic interactions between the fragments and the c‐MYC G4. Similarly, compound 12 served as a negative control for comparison with 7. The bis‐amino series (Figure 3B) was prepared by nucleophilic aromatic substitution of 5‐chloro‐2‐nitroaniline with piperazine, resulting in compound 41 with a nitroaniline moiety, which was then reduced by Pd/C under hydrogen atmosphere to 42. Compound 42, which contains an o‐phenylendiamine moiety, was N‐alkylated with three alkynyl halides of different linker length to form the homologous series of compounds 43–45 (Figure 3B) carrying 1–3 methylene units in the alkynyl chain. Within this bis‐amino series, we decided to prepare only click products derived from alkyne 45 with 3 methylene units because the previously performed SAR study regarding the mono‐amino series (Table 2 for PEA results, and Table 3 for in situ click results) showed that the Pu27‐stabilizing activity of click products 35 and 38 positively correlated with the length of the alkynyl linker: the N‐alkynyl chain with three methylene units showed the best Pu27 stabilizing activity. Furthermore, azides 54 and 55 provided the most active mono‐amino click products. However, the analogous direct click reaction of the bis‐amino alkyne derivative 45 with azides 54 and 55 was not performed due to the low stability of the o‐phenylendiamine moiety. Instead, o‐nitroaniline compound 41 was alkylated with 5‐iodopent‐1‐yne to form 46. In a CuAAC with azides 54 and 55, alkyne 46 formed triazoles 47 and 48, respectively. The resulting o‐nitroaniline click products 47 and 48 were subsequently reduced by Pd/C under hydrogen atmosphere to their diamino counterparts, 49 and 50, and immediately converted into hydrochloride salts to stabilize them. Lastly, compounds 51 and 17 (Figure 3B), bis‐amino analogs of 7, were prepared as described for compounds 41 and 42, respectively: in a nucleophilic aromatic substitution with 1‐methylpiperazine, 5‐chloro‐2‐nitroaniline formed compound 51; compound 17 was then prepared from 51 by reduction of the nitro group by Pd/C under hydrogen atmosphere.
Table 2

SAR data summary showing both the FRET and PEA results at 100 μM. The PEA values (ESI, Section 3.3, Supplementary Figure S3.5–S3.9) are determined as a quotient of stop band density of the respective compound divided by the stop band density of the parent compound 7.

Cpd. No

Structure

PEA at 100 μM

ΔTm/°C FRET at 100 μM

7

1.0

10.4±0.6

12

0.5

3.7±0.5

24

0.1

3.3±0.4

25

0.1

2.4±0.9

26

0.5

2.4±0.4

27

0.4

−2.3±0.7

28

0.5

−1.9±0.3

29

0.5

−2.7±0.2

30

0.6

−1.4±0.3

31

0.5

−2.5±0.4

32

0.7

−2.3±0.3

33

0.7

3.6±0.5

34

0.9

3.6±0.8

35

0.8

4.2±0.8

36

0.5

3.0±0.8

37

0.6

3.9±0.4

38

1.2

7.6±0.4

40

0.1

3.9±0.1

41

0.3

4.1±1.1

42

1.6

>35

43

0.5

13.0±0.9

44

0.5

15.9±1.0

45

1.6

29.5±0.3

46

0.1

5.6±0.4

47

0.5

3.5±0.4

48

0.7

5.1±0.7

49

4.5

33.9±0.2

50

4.5

>35

51

0.1

1.0±1.0

17

1.6

>35

Table 3

The relative formation yields of compounds 27–38 given by reaction ratios. X‐1, Y‐1, and Z‐1‐the combination reactions of three alkynes with the corresponding azides; A, B and C‐in situ click reactions with and without Pu24 and a control reaction, respectively. The ratio was calculated by comparing the area of specific m/z value from the extracted ion chromatography in LC‐MS experiment.

Compound

CH2

Experiment X‐1

Experiment Y‐1

Experiment Z‐1

units

A/B

A/C

A/B

A/C

A/B

A/C

27

1

1.8

1.3

28

2

1.7

1.3

29

3

4.4

3.0

30

1

1.4

1.2

31

2

1.5

1.2

32

3

2.5

1.9

33

1

7.1

4.7

6.6

5.1

34

2

5.2

3.1

7.4

4.4

35

3

22.7

10.8

55.0

42.7

36

1

4.8

3.8

5.4

4.5

37

2

3.4

2.5

3.7

2.6

38

3

9.8

5.5

16.9

10.5

FRET and PEA results at 100 μM for commercial compound 7 derivatives 12–23 in comparison to the parent molecule 7. Cpd. No PEA at 100 μM ΔTm/°C FRET at 100 μM 7 1.0 10.4±0.6 12 0.2 3.7±0.5 13 0.2 0.0 14 −0.3 15 0.2 1.6 16 0.6 1.7 17 1.1 >35 18 0.2 1.1 19 0.3 1.8 20 0.1 0.9 21 0.2 1.2 22 0.2 1.1 23 0.2 1.1 SAR data summary showing both the FRET and PEA results at 100 μM. The PEA values (ESI, Section 3.3, Supplementary Figure S3.5–S3.9) are determined as a quotient of stop band density of the respective compound divided by the stop band density of the parent compound 7. Cpd. No Structure PEA at 100 μM ΔTm/°C FRET at 100 μM 7 1.0 10.4±0.6 12 0.5 3.7±0.5 24 0.1 3.3±0.4 25 0.1 2.4±0.9 26 0.5 2.4±0.4 27 0.4 −2.3±0.7 28 0.5 −1.9±0.3 29 0.5 −2.7±0.2 30 0.6 −1.4±0.3 31 0.5 −2.5±0.4 32 0.7 −2.3±0.3 33 0.7 3.6±0.5 34 0.9 3.6±0.8 35 0.8 4.2±0.8 36 0.5 3.0±0.8 37 0.6 3.9±0.4 38 1.2 7.6±0.4 40 0.1 3.9±0.1 41 0.3 4.1±1.1 42 1.6 >35 43 0.5 13.0±0.9 44 0.5 15.9±1.0 45 1.6 29.5±0.3 46 0.1 5.6±0.4 47 0.5 3.5±0.4 48 0.7 5.1±0.7 49 4.5 33.9±0.2 50 4.5 >35 51 0.1 1.0±1.0 17 1.6 >35 The relative formation yields of compounds 27–38 given by reaction ratios. X‐1, Y‐1, and Z‐1‐the combination reactions of three alkynes with the corresponding azides; A, B and C‐in situ click reactions with and without Pu24 and a control reaction, respectively. The ratio was calculated by comparing the area of specific m/z value from the extracted ion chromatography in LC‐MS experiment. Compound CH2 Experiment X‐1 Experiment Y‐1 Experiment Z‐1 units A/B A/C A/B A/C A/B A/C 27 1 1.8 1.3 28 2 1.7 1.3 29 3 4.4 3.0 30 1 1.4 1.2 31 2 1.5 1.2 32 3 2.5 1.9 33 1 7.1 4.7 6.6 5.1 34 2 5.2 3.1 7.4 4.4 35 3 22.7 10.8 55.0 42.7 36 1 4.8 3.8 5.4 4.5 37 2 3.4 2.5 3.7 2.6 38 3 9.8 5.5 16.9 10.5 In conclusion, FRET and PEA evaluation of various 4‐(piperazin‐1‐yl)aniline derivatives showed that the amino group at the para‐position of the aromatic ring was found necessary for interaction of the ligand with c‐MYC. Also, an additional amino moiety in position 2 of the aromatic ring further increased the c‐MYC stabilizing potency. Therefore, we constructed a fragment library that contained the mono‐amino series directly inspired by the parent 7 molecule and the bis‐amino series with an additional NH2‐ group. Both series included the clickable fragments alkynylated on the piperazine nitrogen as well as the respective click products resulting from CuAAC with selected cationic azides.

Structure‐Activity Relationships

Here, we investigated how different chemical moieties, present in compound 7 derivatives, and their respective positions contribute to c‐MYC G4 stabilization. For this purpose, a starting ligand concentration of 100 μM was used in both the FRET and PEA biochemical assays; the results are compared to the parent compound 7 and summarized in Table 2 (for PEA gel images, see ESI, Section 3.3, Figure S3.5 to S3.9. Amino groups are a common feature of well‐established G4 ligands because they bind to phosphate groups of the G4 backbone via electrostatic interactions mediated by bridging water molecules. As expected, the fragments containing amino groups 7 and 17 exhibited higher stabilization activity at 100 μM in both FRET and PEA than their nitro analogs 12 and 51, respectively (Table 2), suggesting that a free amino group in para‐position of the aromatic ring is required for the interaction between the ligand and the c‐MYC G4. Additionally, a higher number of amino groups also showed enhanced c‐MYC affinity (Table 2, e. g., 17 versus 7). These results confirm the original findings obtained during FRET and PEA evaluation of commercial derivatives of compound 7 (Table 1).
Table 1

FRET and PEA results at 100 μM for commercial compound 7 derivatives 12–23 in comparison to the parent molecule 7.

Cpd. No

PEA at 100 μM

ΔTm/°C FRET at 100 μM

7

1.0

10.4±0.6

12

0.2

3.7±0.5

13

0.2

0.0

14

−0.3

15

0.2

1.6

16

0.6

1.7

17

1.1

>35

18

0.2

1.1

19

0.3

1.8

20

0.1

0.9

21

0.2

1.2

22

0.2

1.1

23

0.2

1.1

Apart from that, we found that the piperazine moiety of 4‐(piperazin‐1‐yl)aniline can be N‐alkylated at the N 4 position by different‐length alkynyl groups (with one to three methylene units) without affecting its ability to bind to G4. This was observed in scaffolds derived from the compound 17 carrying two amino groups at the aromatic ring (43–45), whereas the activity was abolished in mono‐amino derivatives (24–26). Interestingly, we observed considerable restoration of the G4 stabilizing activity for the click products 34–35 (in PEA) and 38 (in both PEA and FRET), all of which were prepared from the N‐alkynylated mono‐amino derivatives (Table 2). In general, click products 33–38, derived from compounds 54 and 55, exhibited partially restored FRET and PEA activity when compared to the parent compound 7, although the extent of activity restoration varied widely. Nevertheless, all these click products showed overall better activity than click products 27–32, derived from 52 and 53, which exhibited a small decrease in Pu25 melting temperature in FRET at 100 μM, indicating their inactivity. Moreover, the click product 38 derived from compound 26 with three methylene units in the alkynyl linker was more active in both FRET and PEA than its shorter‐linker analogs, compounds 36 and 37. A similar trend was also observed in FRET for the click product 35 and its analogs 33 and 34, although the difference in activity was rather small. It is obvious that increased flexibility of the central part of the molecule facilitates interaction of certain ligand moieties with c‐MYC. Accordingly, previously performed studies[ , , , ] also reported the impact of the linker length or side‐chain length and thus molecule flexibility on interaction with various G4 s. Taken together, these results show that a simple N ‐alkynylation of the piperazine moiety at the 4‐(piperazin‐1‐yl)aniline template can destroy the binding activity of the resulting mono‐amino fragment, but an additional click reaction of the inactive molecule with a suitable azide can lead to a click product with partly restored activity. Generally, the bis‐amino series exhibited higher affinity towards c‐MYC than the mono‐amino series. The FRET activity of piperazine‐alkylated bis‐amino compounds 43–45 was lower than that of the bis‐amino standard 17, albeit similar to or better than the activity of the mono‐amino template 7. Both bis‐amino click products 49 and 50 exhibited a significant increase in activity in FRET experiments at 100 μM, which was comparable to that of 45 and 17 and even 3‐fold higher than the activity of 7 (Table 1). Moreover, based on PEA measurements, 49 and 50 appeared to be strongest ligands prepared in this study with 4.5‐fold activity increase compared to compound 7 and significantly higher activity than 45 and 17. The inactivity of the parent nitroaniline compounds 47 and 48 underlines the importance of the aromatic 1,2‐diamino moiety in 49 and 50 for Pu27 stabilization potency. Interestingly, the alkynylated derivatives of both series as well as most mono‐amino click products exhibited decreased activity when compared to the respective parent molecule 7 or 17. We hypothesize that alkynylated derivatives and click products interact with the G4 structure via both the 4‐(piperazin‐1‐yl)‐aniline motif and the alkynyl chain or triazole residue, respectively. If the linker connecting the piperazinyl moiety with the triple bond or triazole ring is short, the molecule is rigid and interacts with G4 via both moieties inefficiently. This leads to activity decrease of such fragment. On the other hand, three methylene units in the linker provide the molecule with increased flexibility that facilitates effective binding of the molecule to the G4 structure via both moieties. This way we could explain activity restoration in the case of the mono‐amino click product 38 and the bis‐amino alkyne 45, and PEA activity increase in the case of the bis‐amino click products 49 and 50. As compounds 42–45, 49–50, and 17 from the bis‐amino series exhibited sufficiently increased c‐MYC stabilization potential at 100 μM, they were also evaluated by comparative FRET assay at 50 μM together with their o‐nitroanaline analogues 41, 46–48, and 51 for their G4‐specificity over duplex DNA; the parent compound 7 and its nitro‐analogue 12 were included for comparison. Therefore, apart from using F‐myc25T, all these compounds were tested in control FRET experiments with a dual‐labelled FdsT oligonucleotide containing a 26‐mer ′Q sequence′ (ds26) that forms a double‐stranded hairpin. The FRET results for F‐myc25T and FdsT at 50 μM are displayed in Figure 4 (FRET data available in ESI, Section 3.5, Table S3.1). The data regarding c‐MYC stabilization showed significantly increased ΔT m values of the amino‐, resp. bis‐amino derivatives in comparison with their nitro‐, resp. o‐nitroaniline analogs. In addition, the FRET activity of the homologous series of bis‐amino alkynes 43–45 at 50 μM increased with the number of methylene units in the alkynyl linker, which is in line with the FRET measurements at 100 μM (Table 2). The control FRET experiments with FdsT showed in most cases zero stabilization potential at 50 μM. Although a slight ΔT m increase was observed for compound 42, the value was negligible when compared to ΔT m increase induced for c‐MYC (F‐myc25T) stabilization. Therefore, we can conclude that our ligands, especially the bis‐amino compounds 17, 42, 45, 49, and 50, selectively interact with the c‐MYC G4 motif. The compounds 17, 42, 45, 49, and 50 were tested in a competitive FRET assay at 25 μM and 10 μM concentration. For each ligand concentration, two parallel FRET experiments were performed: one with F‐myc25T (0.2 μM), and the second with the mixture of F‐myc25T (0.2 μM) and 10‐fold excess of non‐labelled oligonucleotide ds26 (2.0 μM). The results are summarized in Figure 5 (FRET data available in ESI, section 3.5, Table S3.2). In spite of an apparent ΔT m decrease in competitive assays in the presence of the 10‐fold excess of ds26, all compounds retained their c‐MYC stabilization ability. However, a significant ΔT m decrease was observed at lower ligand concentration, especially for click products 49 and 50 that showed almost zero activity at 10 μM. Moreover, activity of compounds 17 and 42 at 10 μM was below 10 °C. Therefore, competitive FRET measurements at lower concentrations were not performed as no compound activity would be expected.
Figure 5

Competitive FRET analysis at 25 μM and 10 μM using F‐myc25T and ds26 in the 1 : 10 ratio. The assay was performed only for selected compounds that exhibited significant FRET activity at 50 μM.

Comparative FRET analysis at 50 μM using F‐myc25T and FdsT (control), performed with the bis‐amino series in compaison to compounds 7 and 12 of the mono‐amino series. Competitive FRET analysis at 25 μM and 10 μM using F‐myc25T and ds26 in the 1 : 10 ratio. The assay was performed only for selected compounds that exhibited significant FRET activity at 50 μM. Average intensity of click products 27–29 and 33–35 during in situ click experiment X‐1. Average intensity of click products 30–32 and 36–38 during in situ click experiment Y‐1. Average intensity of click products 33–38 during in situ click experiment Z‐1. Additionally, control PEA experiments were performed with selected compounds to exclude a different inhibition mechanism of the polymerase chain reaction, e. g. by forming a non‐canonical PEA bulge. In regard of the control assay, we used a G4‐non‐forming oligonucleotide template ′Pu27 all‐mut′ along with Pu27 on the same gel. In this control assay, we tested the parent compound 7 (100 μM) and its bis‐amino analogue 17 (100 μM), the well‐established c‐MYC ligand TMPyP4 (1 μM), 1‐methyl‐1H‐indol‐5‐amine (5AMI, 500 μM) reported as a c‐MYC binder by Nasiri et al, and a KCl solution (100 μM) to observe the effect of G4 stabilization by the K+ ion. The results (ESI, Section 3.4, Figure S3.10) clearly showed formation of a stop product in the presence of the Pu27 template strand for all compound‐containing samples (7, 17, TMPyP4, and 5‐AMI) at given concentrations. Moreover, the 100 μM KCl solution produced the stop band as well, as the K+ ions efficiently stabilized the G4 s formed within the Pu27 sequence. In contrast, no stop band was observed in the presence of the Pu27 all‐mut template for any of the samples including the standard TMPyP4, 5AMI, and the KCl solution. Therefore, we can confirm that in PEA, the mechanism of stopping the chain reaction is due to G4 formation induced by the compounds evaluated in this study. Accordingly, the c‐MYC stabilization potential of the compounds tested corresponds with density of their stop band. Taken together, both the FRET and PEA assays showed that all compounds of the bis‐amino series, especially the compounds 17, 42, 45, 49, and 45, are substantially stronger c‐MYC ligands than compounds of the mono‐amino series. The requirement for the free amino group in para‐position of the aniline moiety was confirmed as the fragments containing amino groups from both series exhibited better c‐MYC stabilization efficiency in FRET and PEA than their respective nitro‐ or o‐nitroaniline‐ analogues. Furthermore, partial restoration of FRET and PEA activity was observed for mono‐amino click products 33–38, which originated from azides 54 and 55 containing a tertiary amino moiety. Moreover, FRET activity of these mono‐amino click products 33–38 as well as of the bis‐amino alkynes 43–45 positively correlated with the number of methylene units in the alkynyl linker. Finally, FRET and PEA control experiments performed with G4 non‐forming templates confirmed validity and relevance of our measurements.

KTGS Using In Situ Click Experiments

To evaluate the co‐catalytic activity of G4 on formation of the respective click products, a series of in situ click experiments employing the 1,3‐dipolar azidealkyne cycloaddition was carried out. However, KTGS was performed only for the mono‐amino series, because the bis‐amino alkynes 43–45 suffered from poor stability as reported above regarding their synthesis and isolation. It was assumed that performing a direct click reaction of the bis‐amino alkynes 43–45 with azides 52–55 in aqueous solution, in the presence of air, and under prolonged (2‐hour) incubation at RT would lead to a quick oxidation of the bis‐amino moiety. Additionally, we decided to carry out all in situ click experiments with a catalytic amount of CuI species, as our preliminary experiments serving for layout optimization did not show any product formation in the absence of copper catalysis (data not shown). The same finding regarding the lack of product formation in the absence of the CuI species was also reported earlier in the study targeting H‐Telo. For the mono‐amino series, three sets of copper catalyzed in situ click experiments were set up. Each experiment combined three homologous alkynes 24–26 with two different azides to form the 1,4‐click products (the combination reactions of three alkynes with the corresponding azides are denoted here as X, Y and Z). For the products of X, Y, and Z reactions, three different in situ click experiments were performed simultaneously: with Pu24 (A), without Pu24 (B), and a control reaction (C), wherein Pu24 was added just before quenching the reaction with TFA. All experiments were performed in triplicates. Experiment X consisted of in situ click reactions of alkynes 24–26 with azides 52 and 54 resulting in the click products 27–29 and 33–35, respectively. Experiment Y combined alkynes 24–26 with azides 53 and 55 resulting in click products 30–32 and 36–38, respectively. Based on previously performed PEA measurements that identified the click products of azides 54 and 55 more active than click products derived from azides 52 and 53, we performed an additional in situ click reactions (experiment Z) combining alkynes 24–26 with azides 54 and 55 to obtain click products 33–38. The average yields of the in situ click experiments A−C for all 6 products of reactions X−Z are shown in Figure 6 and 5 and in ESI, Section 7, Table S7.1, S7.3, S7.5 and Chart S7.1, S7.3, S7.5. The LC residues (alkyne precursors) are shown in ESI, Section 7, Table S7.2, S7.4, S7.6 and Chart S7.2, S7.4, S7.6. In a standard in situ click experiment, detecting a click product in a templated reaction directly suggests the templating effect. However, the amounts of the triazole formed in complex reaction mixtures are usually small and difficult to detect and quantify. Therefore, all in situ click experiments contained catalytic copper to increase triazole adduct formation and to facilitate subsequent analysis. Furthermore, the co‐catalytic effect of Pu24 G4 is expressed as an A/B ratio of area integral of specific m/z in experiment A (with Pu24) and B (without Pu24). Experiment C and the related A/C ratio were introduced to assess the Pu24 effect on the LC/MS analysis. All compounds 27–38 were prepared with increased yields in the presence of Pu24, thus suggesting a possible co‐catalytic activity for G4 during the formation of the click products (Table 2, A/B and A/C ratios). Our data revealed that the presence of three methylene units at the alkynyl chain attached to the N 4 position of the piperazine moiety increased the stability and yield of the reaction products 29, 32, 35, and 38, with no significant differences in compounds with one and two methylene units (Table 3). Moreover, the A/B and A/C ratios of in situ click products derived from azides 54 and 55 were higher than those of click products derived from azides 52 and 53. In this regard, click products 33–35 derived from azide 54 had the highest A/B and A/C ratios. Compound 35 had the highest yield of the in situ click experiments, followed by 38, both of which were derived from compound 26 with the longest alkynyl linker (3 methylene units). These results were in agreement with the previously performed SAR study (Table 2) except for compound 38, which showed higher activity in PEA than 35. Interestingly, the control reaction C showed small but significant increases in reaction yields when compared with B, suggesting that adding Pu24 oligonucleotide just before quenching leads to rapid click product formation. Therefore, the A/B ratio should be considered the corresponding relative formation yield of a compound. Furthermore, control in situ click experiments were performed to confirm that the co‐catalytic activity of the Pu24 oligonucleotide on ligand assembly is due to the G4 secondary structure formed. The control in situ click experiments were carried out with a 26‐mer ′Q sequence′ (ds26) that forms a double‐stranded hairpin, and in the same manner as the standard in situ click experiments using the G4‐forming Pu24 oligonucleotide. The results (ESI, Section 7, Table S7.7, S7.9, S7.11 and Chart S7.7, S7.9, S7.11 for click products; Table S7.8, S7.10, S7.12 and Chart S7.8, S7.10, S7.12 for alkyne precursors) showed no remarkable product formation increase in experiments A with ds26 over experiments B without ds26 and the control experiment C, because the A/B and A/C ratios were in most cases close to 1.0 (ESI, Section 7, Table S7.13). A substantial A/B and A/C ratio decrease for some compounds – especially for click products 27, 28, and 30 derived from azides 52 and 53 with a primary amino moiety‐suggests their binding to the double‐stranded ds26 sequence. Nevertheless, based on the results obtained, we can assume that the increase of click product formation in presence of Pu24 is the outcome of the c‐MYC G4 co‐catalytic activity. Overall, KTGS performed for the mono‐amino series in the presence of a copper catalyst showed the same SAR trends regarding c‐MYC affinity as FRET and PEA biology assays. The formation yield in the presence of Pu24 was substantially higher for click products containing three methylene units at the piperazinetriazole linker than for compounds with one and two methylene units. It is apparent that increased flexibility of the aliphatic linker attached to the central scaffold facilitates suitable orientation of key structural motifs and thus efficient interaction of the ligand with c‐MYC. Moreover, the yield of click product formation derived from azides 54 and 55 containing a tertiary amino moiety was higher than for click products derived from azides 52 and 53 bearing a primary amino moiety. Our results of control in situ click experiment with G4 non‐forming oligonucleotide showed no substantial increase of click product formation. Therefore, we can suppose that the click product formation yield increase in presence of Pu24 is due to the c‐MYC G4 co‐catalytic activity.

Structural Basis of Compound Binding

The G4 core of Pu24 is formed by the three guanine tetrads (Figure 4A; ESI, Section 8, Figure S8.1).[ , ] To assess the binding modes of the studied compounds, we followed chemical shift changes in the guanine imino‐region of 1H NMR spectra of the Pu24‐formed G4 upon ligand addition. In particular, the compounds were sorted based on the perturbation or disappearance of individual assigned imino signals in Pu24 into three distinct classes (Figure 4B). The class I ligands induced 5′ G‐tetrad destabilization because the imino signals of G4, G13, G8 and G17 disappeared. The residues from the central (G18, G5, G14) and from the 3′ (G15, G6, G19) G‐tetrad were shifted significantly, indicating stacking or intercalation of these compounds. The class II compounds induced perturbations within the 5′ G‐tetrad (G4, G13, G8 and G17) and central G‐tetrad (G5, G14), indicating stacking of the ligand on the top. The class III compounds induced only perturbations of two guanine NH signals from the 5′ G‐tetrad (G4, G17), suggesting a specific interaction with only a minimal effect on the overall conformation of the Pu24 oligonucleotide. The compounds inducing no significant change in the imino region were classified as non‐binders.
Figure 4

Comparative FRET analysis at 50 μM using F‐myc25T and FdsT (control), performed with the bis‐amino series in compaison to compounds 7 and 12 of the mono‐amino series.

The classification is summarized in Figure 9B (schematic changes within NMR spectra are shown in ESI, Sections 8.1–8.4, Figures S8.2–S8.6). The class I binders 42, 49, 50, and 17 (ESI, Section 8.1, Figure S8.2) contained a bis‐amino moiety and exhibited high Pu24‐stabilizing activity in both PEA and FRET. In addition, 49 and 50 were the most active click products prepared in this study. All the class I binders induced significant shifts in selected peaks and extreme broadening of other peaks, indicating 5′ G‐tetrad disruption and possible binding on the top of the central tetrad or a ligand intercalation between the central tetrad and the 3′ tetrad. The class II binders comprised the homology series of bis‐amino N‐alkynylated derivatives 43–45 and the o‐nitroaniline click products 47 and 48 (ESI, Section 8.2, Figure S8.3). These ligands were selectively bound only to the 5′ G‐tetrad, and this mode of interaction did not disrupt the G4 structure. The compounds in class III carried a nitro group: 46 and 51 were o‐nitroaniline derivatives, and 40 was a click product with a nitro group on the aromatic ring and served as a negative control for compound 38 in SAR (ESI, Section 8.3, Figure S8.4). This interaction mode should be the weakest because only two guanine NH signals from the 5′ G‐tetrad were affected. Moreover, chemical shift changes were only moderate compared with class I and II compounds. Correspondingly, the activity of 40, 46 and 51 was similar to that of the negative control in PEA and lower than that of 7 in FRET.
Figure 9

(A) Schematic representation of the Pu24 oligonucleotide. Individual G‐tetrads are color‐coded. (B) Three distinctive classes of binding ligands were identified by changes in the peaks of individual guanine NH groups within the amidic region of 1H NMR.

(A) Schematic representation of the Pu24 oligonucleotide. Individual G‐tetrads are color‐coded. (B) Three distinctive classes of binding ligands were identified by changes in the peaks of individual guanine NH groups within the amidic region of 1H NMR. No significant effects were observed in the imino regions of NMR spectra of all mono‐amino click products 27–38, their N‐alkynylated clickable precursors 24–26, non‐alkylated o‐nitroaniline derivative 41, compound 12 as a nitro‐analog of 7 and, surprisingly, compound 7 itself (ESI, Section 8.4, Figure S8.5 and S8.6). For compounds 12, 24–26, and 41 and for most mono‐amino click products, this result is consistent with FRET (zero or only partially restored activity compared to 7) and PEA (activity similar to negative control) assays, which suggest low binding affinity to c‐MYC G4. However, this category also includes the template molecule 7 and several mono‐amino click products, 34, 35, 37, and 38, which exhibited some stabilizing activity both in FRET or PEA, and their formation was promoted in the presence of Pu24 during in situ click experiments. Hence, these compounds likely have an alternative binding mechanism, which does not perturb imino groups in the core G4 tetrads. Notably, mono‐amino click products 27–32 that exhibited small negative ΔT m values in FRET, were also classified as non‐binders by 1H NMR as they did not induce any G4 signal perturbation. In summary, we evaluated compounds of our fragment library for their c‐MYC G4 binding mode using 1H NMR spectroscopy. Based on our results, it is apparent that the bis‐amino compounds 17, 42, 49, and 50 that belonged to the most active ligands according to FRET and PEA biology assay also exhibited the strongest c‐MYC binding mode (class I binders). Additionally, most of the remaining compounds of the bis‐amino series belonged either to the binder class II or III, both of which represent a weaker binding mode. On the other hand, all compounds of the mono‐amino series, including the parent compound 7, were determined as non‐binders. These findings are in accordance with FRET and PEA results that revealed mono‐amino compounds as less active than compounds of the bis‐amino series.

Conclusions

Stabilization of G‐quadruplexes formed in the c‐MYC promoter region may be a viable strategy for anticancer therapy. We used the 4‐(4‐methylpiperazin‐1‐yl)aniline molecule, identified in a previously published study as a c‐MYC ligand, as a template for the SAR‐guided design of a small focused fragment library suitable for click chemistry. The biochemical assays revealed that the presence of a free amino substituent at the aromatic ring was essential for stabilizing potency of this type of molecules and that an additional amino group at position 2 further increased their activity. Moreover, the piperazine ring was amenable to Nalkynylation, which allowed subsequent click reactions, with an optimal length of three methylene units. We subjected the scaffolds to ‘conventional’ and in situ click reactions in the presence of Pu24. For the mono‐amino click products, the G4‐stabilizing activity and their in situ formation yield positively correlated with the increase in the number of methylene units in the alkynyl chain. Similarly, in the bis‐amino series of N‐alkynyl derivatives, we observed no change in activity in compounds with one and two methylene units, but we detected significant increases in activity in compounds with three methylene units. Using 1H NMR spectroscopy, we probed the mode of interaction for the studied compounds. Interestingly, the most potent bis‐amino compounds, including the N‐alkynyl homologs and their click products, were destabilizing the 5’ guanine tetrad and most likely stacking on the top of the central tetrad. Our study suggests that the bis‐amino derivatives of the 4‐(piperazin‐1‐yl)aniline template, including the click products, appear to be potent c‐MYC G4 stabilizers in FRET, PEA, and NMR at low micromolar concentrations and may be amenable to further therapeutic development.

Experimental Section

Oligonucleotides

The HPLC‐purified Pu24 oligo‐deoxyribonucleotide mimicking c‐MYC G4 as well as the HPLC‐purified ds26 oligo‐deoxyribonucleotide forming a double‐stranded hairpin were purchased in lyophilized form from Generi Biotech (www.generi‐biotech.com): Pu24: 5’‐TGA GGG TGG GGA GGG TGG GGA AGG‐3’ Ds26: 5’‐TAT AGC TAT ATT TTT TTA TAG CTA TA‐3’ Each lyophilizate was dissolved in 20 mM KH2PO4, 70 mM KCl, NaN3 (0.02 %), pH 7.0 to the final concentration of 15 μM. Subsequently, the solution was annealed at 95 °C for 15 minutes and allowed to gradually cool down to room temperature (RT), adopting the typical ‘propeller’ shaped conformation.

FRET

The dual‐labelled oligonucleotides Fc‐myc25T and FdsT (5′‐FAM and 3′‐TAMRA) were purchased from Sigma‐Aldrich®. Regarding Fc‐myc25T, the shorter sequence of the NHEIII1 region (Pu27 or c‐MYC G4) was used. This sequence contains only five G‐tracts, enabling folding in 1–4 and 2–5 c‐MYC G4 conformers. The last GG was removed to increase FRET efficiency. The sequence of the Fc‐myc25T oligonucleotide is: Fc‐myc25T: 5′‐FAM‐TGGGGAGGGTGGGGAGGGTGGGGAA‐TAMRA‐3′ On the contrary, the FdsT used for control measurements contained a 26‐mer Q‐sequence (ds26) forming a double‐stranded hairpin: FdsT: 5′‐FAM‐TATAGCTATATTTTTTTATAGCTATA‐TAMRA‐3′ All FRET melting experiments were performed in 10 mM Cacodylate buffer (pH=7.2) containing 95 mM LiCl and 5 mM KCl. Oligonucleotides were heat‐denatured at 95 °C for 10 minutes and cooled by approximately 1 °C per minute to RT. A 384‐well plate was used, with each well containing the dual‐labelled oligonucleotide at a final concentration of 0.2 μM in 20 μl. In competitive FRET experiments with 0.2 μM of F‐myc25T, ten‐fold excess of non‐labelled ds26 oligonucleotide was added to the mixture to reach the final concentration of 2.0 μM. All compounds dissolved in DMSO to a concentration of 10 mM were loaded into the wells using an ECHO® 550 acoustic liquid handler with final concentrations of 100 μM with 1 % DMSO. Melting curves were measured on a LightCycler® 480 Instrument II by monitoring FAM fluorescence (Syber green I channel, with excitation wavelength at 465 nm and emission at 510 nm). Melting points were calculated in GraphPad Prizm 5 using the asymmetric five parameter model. The ability of a particular fragment to stabilize the secondary structure of the Pu25 (Fc‐myc25T) or ds26 (FdsT) oligonucleotide was expressed as a difference between the melting points of the sample and of a control. Each test was performed in duplicates and repeated in three independent experiments (n=3).

DNA Polymerase Extension Assay (PEA)

In PEA, the movement of DNA polymerase on the template produces a stop band if the G4 blocks are folded. Both the primer and the template were purchased from Sigma‐Aldrich® (www.sigmaaldrich.com). The primer was labelled on the 5 – end with 32P using T4 polynucleotide kinase (TaKaRa ref: 2021 A) according to the manufacturer's instructions. P‐30 colons were used to remove unbound radioactivity. The labelled primer and the template were mixed in water in a 1 : 1.25 ratio, heat‐denatured at 95 °C for 10 minutes and cooled approximately 1 °C per minute to RT. The template concentration in the primer/template mixture was 12.5 μM. The polymerase stop reaction was performed using a GoTaq® G2 DNA polymerase kit (PROMEGA ref: M784A); the reaction was run in 1X Colorless GoTaq® Reaction Buffer. The final reaction volume was 20 μl and contained 0.1 μM template (primer/template mixture), 200 μM dNTP, and either compounds in DMSO solution or DMSO as a control. The reaction started after 30‐minute incubation at 52 °C (optimized temperature) by adding 2 μL of DNA polymerase (1 U/μL) to reach 0.1 U per well and further incubated at 52 °C for 30 minutes. At the end, the reaction was stopped by adding 5x loading solution (80 % formamide, 10 % glycerol, 20 mM EDTA pH 8, 0,025 % xylene cyanol and 0,025 % bromophenol blue), heat‐denatured for 5 minutes at 95 °C, subsequently cooled on ice and kept at −20 °C until separation on a 15 % AA denaturating gel containing 40 % of urea at 55 °C, vacuum dried and visualized using phosphoimaging cassettes and scanned on the TyphoonTM FLA 5500 at 100 μM resolution. Band densities were evaluated by Image Quant software and data were normalized using the following formula: The data were determined as a quotient of stop band density of the respective compound divided by the stop band density of the parent compound 7, which was present on each gel. All compounds were screened at 100 μM concentration with 5 % of DMSO. Template Pu27: 5′‐CTGCGATCCGTCAGTCCAACATGCTATACT‐ ‐GGGGAGGGTGGGGAGGGTGGGGAAGG‐ TTAGCGGCACGCAATTGCTAGCGTGAGTCG‐3′ Reverse primer: 5′‐CGACTCACGCTAGCAATTGCGTG‐3′ For control PEA measurement, the template strand containing the Pu27 ′all‐mut′ sequence incapable of G4 formation was used: Pu27 ′all‐mut′: 5′‐CTGCGATCCGTCAGTCCAACATGCTATACT‐ ‐GAAGAGAGTGAAGAGAGTGAAGAAGG‐ TTAGCGGCACGCAATTGCTAGCGTGAGTCG‐3′

Chemistry

The mono‐amino series (Figure 3A) was synthesized via an N‐alkylation reaction of the piperazine moiety at the 4‐(piperazin‐1‐yl)aniline with the respective alkynyl halides under basic conditions, thereby preparing a homologous series of three 4‐(piperazin‐1‐yl)aniline‐derived alkynes with different alkynyl chain lengths, 24, 25, and 26 (ESI, Section 4, Scheme S‐1). Compounds from the bis‐amino series (Figure 3B) were synthesized as follows: firstly, compound 41 was prepared by nucleophilic aromatic substitution of 5‐chloro‐2‐nitroaniline with piperazine under basic conditions, then reduced by catalytic hydrogenation on Pd/C forming the compound 42 (ESI, Section 4, Scheme S‐2). Finally, 42 was N‐alkylated under basic conditions with the respective alkynyl halide to obtain compounds 43–45 (ESI, Section 4, Scheme S‐2). The alkyne derivatives of both families formed 1,4‐disubstituted triazole compounds by CuAAC. The alkynyl compounds from the mono‐amino series, 24–26 (Figure 3A), were directly mixed with 3‐azido‐N,N‐dimethylpropan‐1‐amine in the presence of catalytic amounts of CuI upon triazole formation. The CuAAC reaction products 33–35 showed sufficient yields (ESI, Section 4, Scheme S‐3). Similarly, CuAAC reactions were performed with 1‐(2‐azidoethyl)pyrrolidine to form compounds 36–38, with 2‐azidoethan‐1‐amine to form compounds 27–29, and with 3‐azidopropan‐1‐amine to form compounds 30–32. All click products were isolated in good yields (ESI, Section 4, Scheme S–3). A direct CuAAC reaction of the bis‐amino derivatives (Figure 3B, 43–45) was not performed due to the low stability of the o‐phenylendiamine moiety. Instead, the nitro compound 41 was alkylated under basic conditions in the presence of 5‐iodopent‐1‐yne to form 46 (ESI, Section 4, Scheme S‐5). Then, subsequent CuAAC reactions of 46 with 3‐azido‐N,N‐dimethylpropan‐1‐amine or 1‐(2‐azidoethyl)pyrrolidine were performed to form compounds 47 and 48 (ESI, Section 4, Scheme S‐5). Both 47 and 48 were subsequently reduced by hydrogenation on Pd/C to their bis‐amino counterparts, 49 and 50. To avoid decomposition of the bis‐amino compounds, the respective hydrochloride salts were formed immediately after quenching the hydrogenation reaction by adding the HClethanol solution. Furthermore, 1‐(4‐nitrophenyl)piperazine was alkylated with 5‐iodopent‐1‐yne under basic conditions to form compound 39, which was then mixed with 1‐(2‐azidoethyl)pyrrolidine in the presence of catalytic amounts of CuI to afford the compound 40 (ESI, Section 4, Scheme S‐4). Lastly, compounds 41 and 17 were prepared as described for 41 and 42: in a nucleophilic aromatic substitution, 5‐chloro‐2‐nitroaniline was mixed with 1‐methylpiperazine to form 51, and compound 17 was prepared from 51 by reduction of its nitro group by catalytic hydrogenation on Pd/C. The decomposition of the bis‐amino compound 17 was avoided by immediate formation of hydrochloride salt (ESI, Section 4, Scheme S‐6).

In Situ Click Experiments

The reaction mixture for each in situ click experiment contained three alkynes (1.0 mM each), two azides (1.5 mM each), Tris‐HCl buffer (15 mM, pH 7.4), KCl (100 mM), CuSO4 (1.5 mM) and sodium ascorbate (3.0 mM), with (experiment A) or without (experiments B and C) the oligonucleotide Pu24 or ds26 (both 0.1 mM in Tris‐HCl/KCl buffer). In the control experiment (C), the respective oligonucleotide was added to the reaction mixture only 1 minute before quenching the reaction (for more detailed experimental setup, see ESI, Section 6, Table S6.1‐S6.3). After 2 hours of shaking at 300 rpm, 22 °C, trifluoroacetic acid (TFA, 40 % in H2O) was added to quench the reaction by denaturing the DNA. The composition of each reaction mixture was analyzed by LC–MS. The ratio of the integral amount measured by LC–MS of each click product was calculated between experiments A and B (A/B ratio) and between experiments A and C (A/C ratio).

LC–MS Evaluation of in Situ Click Experiments

Samples were injected onto a Luna Omega Polar C18 column 150x1.0 mm (Phenomenex) and separated by gradient of acetonitrile in water (both mobile phases modified by 0.1 % formic acid). The separation was performed by an LC system (I‐class, Waters) coupled to Mass Spectrometer (Synapt G2, Waters) to acquire m/z by positive electrospray ionization in the range of 100–1500 m/z. The extracted ion chromatogram of the monitored peaks was integrated by Quantlynx application of MassLynx 4.1 (Waters).

Hit Validation by 1H NMR Spectroscopy

For the purpose of hit validation by 1H NMR, all tested compounds were dissolved in DMSO‐d 6 to the final concentration of 20 mM. The samples were formulated on one‐to‐one basis to avoid false‐positive hits caused by aggregation of ligands or misinterpretation of complex spectra of mixtures. The stock solution of the target (Pu24) was prepared to match the final concentration of 5 μM, adding 10 % D2O for field locking, in an NMR buffer (pH=7.0) containing 20 mM KH2PO4, 70 mM KCl, and 0.02 % NaN3. Individual ligand solutions were added to a G4 stock solution to match the final 100x excess of ligand (500 μM) over target. Each tested sample was formulated as follows: 14 μL of the DMSO‐d 6 solution containing the respective ligand in 20 mM concentration was added to 536 μL of 5 μM G4 stock solution containing 10 % D2O to obtain final sample volume of 550 μM. This formulation introduced 2.5 % of DMSO‐d 6 from the compound‘s stock solutions. The peak of the residual DMSO‐d 6 (δ=2.50 ppm) was used as an internal reference standard. Therefore, there was no need to add additional internal reference standard which could possibly interfere in the STD 1H NMR experiment. All samples were spun down in Eppendorf Minispin Centrifuge at 12.100 x g for 2 minutes to separate possible aggregates and to remove air bubbles. The samples were transferred into NMR tubes and stored at 4 °C. The 1H NMR experiment was performed on a Bruker Avance III™ HD 600 MHz spectrometer equipped with a Cryoprobe and a sample changer (for a detailed spectrometer setup, see ESI, Section 8). The 1H NMR spectra were acquired using 350/550μL samples of 5 μM Pu24 dissolved in NMR buffer at 293 K and the standard ‘stddiffesgp’[ , ] pulse sequence with excitation sculpting and pulse‐field gradients for water suppression. The frequency of non‐selective irradiation pulse was set to saturate the well‐separated signal of DNA (6824 Hz, amidic region), using a 50 ms shaped Eburp2.1000 pulse at a power of 40 dB. The irradiated signals had to be sufficiently separated from the ligand‘s signals to prevent their direct irradiation, which would generate false positive hits. The spectra were acquired at a free induction decay (FID) resolution of ∼1 Hz. The typical experimental time of each sample was 30 minutes, thus allowing measurements of the whole library within one day.

Conflict of interest

The authors declare no conflict of interest. As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re‐organized for online delivery, but are not copy‐edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors. Supplementary Click here for additional data file.
  50 in total

1.  Design and synthesis of fluoroquinophenoxazines that interact with human telomeric G-quadruplexes and their biological effects.

Authors:  W Duan; A Rangan; H Vankayalapati; M Y Kim; Q Zeng; D Sun; H Han; O Y Fedoroff; D Nishioka; S Y Rha; E Izbicka; D D Von Hoff; L H Hurley
Journal:  Mol Cancer Ther       Date:  2001-12       Impact factor: 6.261

2.  Hoechst 33258 binds to G-quadruplex in the promoter region of human c-myc.

Authors:  Souvik Maiti; N K Chaudhury; Shantanu Chowdhury
Journal:  Biochem Biophys Res Commun       Date:  2003-10-17       Impact factor: 3.575

3.  Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription.

Authors:  Adam Siddiqui-Jain; Cory L Grand; David J Bearss; Laurence H Hurley
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-23       Impact factor: 11.205

Review 4.  Kinetic target-guided synthesis.

Authors:  Xiangdong Hu; Roman Manetsch
Journal:  Chem Soc Rev       Date:  2010-02-02       Impact factor: 54.564

Review 5.  Kinetic target-guided synthesis in drug discovery and chemical biology: a comprehensive facts and figures survey.

Authors:  Damien Bosc; Jouda Jakhlal; Benoit Deprez; Rebecca Deprez-Poulain
Journal:  Future Med Chem       Date:  2016-02-15       Impact factor: 3.808

6.  Spectral studies on 33258 Hoechst and related bisbenzimidazole dyes useful for fluorescent detection of deoxyribonucleic acid synthesis.

Authors:  S A Latt; G Stetten
Journal:  J Histochem Cytochem       Date:  1976-01       Impact factor: 2.479

Review 7.  Click chemistry for drug development and diverse chemical-biology applications.

Authors:  Prakasam Thirumurugan; Dariusz Matosiuk; Krzysztof Jozwiak
Journal:  Chem Rev       Date:  2013-03-27       Impact factor: 60.622

8.  N-phenyl-carbazole-based two-photon fluorescent probes: strong sequence dependence of the duplex vs quadruplex selectivity.

Authors:  B Dumat; G Bordeau; E Faurel-Paul; F Mahuteau-Betzer; N Saettel; M Bombled; G Metgé; F Charra; C Fiorini-Debuisschert; M-P Teulade-Fichou
Journal:  Biochimie       Date:  2011-06-13       Impact factor: 4.079

9.  G-quadruplex nucleic acids as therapeutic targets.

Authors:  Shankar Balasubramanian; Stephen Neidle
Journal:  Curr Opin Chem Biol       Date:  2009-06-08       Impact factor: 8.822

Review 10.  Targeting G-quadruplexes in gene promoters: a novel anticancer strategy?

Authors:  Shankar Balasubramanian; Laurence H Hurley; Stephen Neidle
Journal:  Nat Rev Drug Discov       Date:  2011-04       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.